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The effect of dietary whey protein v. casein on plasma and Liver cholesterol concentrations was 
investigated in female, weanling rats. Balanced, purified diets containing either whey protein or casein, 
or the amino acid mixtures simulating these proteins, were used. The high-cholesterol diets (10 g 
cholesterol/kg feed) had either 150 or 300 g protein or amino acids/kg feed. The diets were fed for 3 
weeks. At the low dietary protein level, whey protein v. casein did not affect plasma total cholesterol, but 
lowered the concentration of liver cholesterol. At the high dietary protein level, whey protein significantly 
lowered plasma and liver cholesterol and also plasma triacylglycerols. The hypocholesterolaemic effect 
of whey protein was associated with a decrease in very-low-density-lipoprotein cholesterol. At the high 
dietary protein concentration, whey protein reduced the faecal excretion of bile acids when compared 
with casein. The effects of intact whey protein v. casein were not reproduced by the amino acid mixtures 
simulating these proteins. It is suggested tentatively that the cholesterol-lowering effect of whey protein 
in rats is caused by inhibition of hepatic cholesterol synthesis. 
Whey protein: Plasma cholesterol: Liver cholesterol: Bile acids: Rat 
The type of dietary protein can influence plasma cholesterol concentration (Kritchevsky, 
1979 ; Beynen, 1990). Animal proteins generally exert a hypercholesterolaemic effect when 
compared with plant proteins (Carroll, 1982). However, different animal proteins may 
cause different degrees of hypercholesterolaemia by different mechanisms (Lovati et al. 
1990). Milk-whey protein instead of casein in formulas fed to infants has been shown to 
lower plasma cholesterol concentrations (Tseng et al. 1990). The hypocholesterolaemic 
effect of dietary whey protein v. casein also occurs in rabbits (Lovati et al. 1990), whereas 
in rats inconsistent results have been obtained (Sautier et al. 1983; Choi et al. 1989). 
In the present study using female rats we re-addressed the question of whether milk-whey 
protein v. casein in the diet influences plasma and liver cholesterol concentrations. In 
contrast to previous work (Sautier et al. 1983; Choi et al. 1989; Laprk et al. 1989) the diets 
containing either casein or whey protein were isonitrogenous and carefully balanced for 
residual fat and cholesterol in the protein preparations. Amino acid mixtures simulating 
either whey protein or casein were fed also to see whether any effects of the intact proteins 
can be explained by their amino acid composition or rather by protein structure or non- 
protein components. The proteins and amino acid mixtures were incorporated into the 
diets at low (1 50 g/kg diet) and high (300 g/kg diet) levels because protein-type effects on 
* For reprints. 
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plasma and liver cholesterol concentrations are generally amplified by higher protein 
intakes (Terpstra et al. 1982; Zhang & Beynen, 1992). All diets used contained a high 
concentration of cholesterol (1 0 g/kg diet) to enhance the differential cholesterolaemic 
responses to the type of protein (Van der Meer & Beynen, 1987). 
M A T E R I A L S  A N D  M E T H O D S  
Diets 
The analysed composition and amino acid profile of the casein (Havero bv, Rotterdam, 
The Netherlands) and milk-whey protein (DMV Campina, Veghel, The Netherlands) 
preparations are shown in Table 1. Either the protein preparations or amino acid mixtures 
simulating either casein or whey protein (Table 1) were used as the only N source in the 
experimental diets. There were two levels of N source: 150 or 300 g protein or amino acid 
mixture/kg diet. The diets containing intact proteins were isonitrogenous and balanced for 
residual fat, cholesterol, Ca, P and Mg in the protein preparations. Dietary cholesterol 
concentration was 10 g/kg. Table 2 gives the ingredient composition of the experimental 
diets. The analysed composition of the diets (Table 3) agreed well with the calculated 
composition. The diets, which were in powdered form, were stored at 4" until feeding. Food 
and demineralized water were provided on an ad lib. basis. 
Animals and experimental procedures 
Weanling, female Wistar rats (Hsd/Cpb: WU), aged about 3 weeks, were used. On arrival 
the rats were given free access to a commercial, pelleted non-purified diet (RMH-B@; Hope 
Farms, Woerden, The Netherlands) and tap water. They were housed in groups of five rats 
in Macrolon TI1 cages (UNO BV, Zevenaar, The Netherlands) with a layer of sawdust as 
bedding. 
After 1 week all animals were transferred to the purified, pre-experimental diet and 
demineralized water. The powdered, pre-experimental diet consisted of the following (g/kg 
diet) : casein 175.3, soya-bean oil 30, coconut fat 87.2, cholesterol 9.96, cellulose 30, glucose 
614.79, CaCO, 12.45, NaH2PO,.2H,O 8.93, MgCO, 1.37, KCI 1.0, KHCO, 7.0, mineral 
premix 10, vitamin premix 12. The composition of the mineral and vitamin premix has been 
described (Grooten et al. 1991). After another week, on day 0 of the experiment, the rats 
were divided into eight groups of twelve animals each on the basis of plasma cholesterol 
concentration and body weight. The eight groups were randomly assigned to the 
experimental diets (Table 2). The rats had ad lib. access to food and demineralized water. 
During the experimental period the rats were housed individually in metabolism cages 
(Tecniplast Gazzada, Buguggiate, Italy). The cages were placed in a room with controlled 
temperature (20-24"), relative humidity (4045 Yo) and lighting (light 06.00-18.00 hours). 
The experiment lasted 21 d. The rats were weighed weekly and feed intake was recorded. 
On day 21 the rats were anaesthetized with xylazine (6.86 mg/kg, administered 
intraperitoneally) and ketamine (60 mg/kg, administered intramuscularly) and ex- 
sanguinated by aortic puncture. Livers were removed and weighed. The heparinized blood 
was centrifuged to collect plasma. Livers and plasma were stored at -20" until analysis. 
Chemical analyses 
N in protein preparations and diets was determined by the Kjeldahl method (Joslyn, 1970). 
Cholesterol in proteins and diets was determined by gas-liquid chromatography (Nordby 
& Nagy, 1973). Crude fat was determined by extraction according to the Soxhlet method 
(Joslyn, 1970), and fatty acid composition by the method of Metcalfe et al. (1966). Ca and 
Mg in the protein preparations were analysed by atomic absorption spectroscopy after dry 
ashing and dissolving the ash in 6 mol HCl/I as described previously (Hoek et al. 1988). 
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Table 1. Analysed composition (g l kg )  of the protein preparations 
Milk-whey 
Dietary protein.. . Casein protein 
Components 
N 1369 120.3 
Crude fat 16.0 71.0 
Cholesterol 0.21 2.1 
Ca 0.12 3.17 
Mg 0.02 0.55 
P 1.30 3.40 
Amino acids* 
Alanine 19.8 39.0 
Aspartate 463 860 
Arginine 30.6 21.0 
Cysteine 2.6 19.0 
Glutamate 175.5 138.0 
Glycine 25.6 15.0 
Histidine 23.2 16.0 
Isoleucine 50.4 55.0 
Leucine 95.2 86.0 
Lysine 62.1 74.0 
Methionine 24.0 17.0 
P h e n y I a 1 an i n e 29.0 
Proline 80.3 49.0 
Serine 28.1 46.0 
Threonine 35.6 60.0 
Tryptophan 11.6 17.0 
Tyrosine 47.2 24.0 
Valine 58.8 52.0 
36.4 
* Values provided by manufacturers. 
Table 2. Ingredient composition (g l kg )  of the experimental diets 
Casein Whey-protein 
Casein Whey protein amino acids amino acids 
Protein or amino 
acid mixture (g/kg feed,, .) 150 300 150 300 150 300 150 300 
Ingredient 
- - - - - ~ Casein 175.3 3506 
Whey protein - - 199.5 399.0 
Casein amino acids* - - 
Soya-bean oil 30 30 30 30 30 30 30 30 
Coconut fat 87.2 84.4 75.8 61.67 90 90 90 90 
Cholesterol 9.96 9.93 9.58 9.16 10 10 10 10 
Glucose 604.83 433.54 596.56 416.92 626.12 476.12 626.12 476.12 
CaCO, 1245 12.39 10.92 9.34 12.5 12.5 12.5 12.5 
MgCO, 1.37 1-36 1.00 0.63 1.38 1.38 1.38 1.38 
~ - - - 
~ ~ ~ - 150 300 
Whey-protein amino acids* ~ - __ ~ - - 150 300 
NaH,PO, .2H,O 18.89 17.78 16.64 13.28 20 20 20 20 
Constant componentst 60 60 60 60 60 60 60 60 
* For composition, see Table 1. 
t Constant components consisted of the following (g/kg feed): cellulose 30, KCI 1.0, KHCO, 7.0, mineral 
premix 10, vitamin premix 12. The composition of the mineral and vitamin premix has been described (Grooten 
et al. 1991). 
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Table 3. Analysed composition ( g l k g )  of the experimental diets 
~ 
~ 
Casein Whey protein 
Protein or amino acid 
mixture (g/kg feed). . . 150 300 150 300 
Casein Whey-protein 
amino acids amino acids 
150 300 150 300 
Component 
Dry matter 953 
N 24.2 
Fat 125 
Cholesterol 12.5 
Ca 5.2 
Mg 0.4 
P 4.8 
Selected fatty acids 
(g methylester/kg methylesters) 
8:O 55 
lo :o  40 
12:o 326 
14:O 135 
16:O 102 
18:O 40 
18: 1 1 I5 
18:2 159 
18: 3n- 3 15 
946 958 
49.1 23.9 
123 116 
10.4 107 
4.5 4.9 
0.4 0 4  
5.4 4.2 
52 49 
38 37 
320 312 
134 I32 
105 105 
41 41 
118 121 
163 173 
16 17 
955 
101 
47.5 
10.9 
4.8 
0.4 
4.3 
48 
34 
287 
122 
107 
41 
130 
196 
19 
963 972 
124 121 
19.6 36.9 
10.5 9.8 
4.9 4.3 
0.4 0.4 
4.9 4.3 
53 55 
39 40 
329 331 
131 137 
103 101 
40 40 
115 113 
157 156 
15 15 
~ ~~ 
966 962 
126 125 
18.1 36.0 
9.7 10.2 
4.9 4.1 
0.4 0.4 
4.3 4.4 
52 57 
38 41 
327 330 
131 136 
103 100 
40 37 
116 114 
158 157 
15 15 
P in the same samples was analysed enzymically using a commercial kit (MA-KIT 
Phosphate; Roche, Basel, Switzerland). 
Cholesterol and triacylglycerols in plasma were measured enzymically using kits 
(Monotest and Test-Combination) supplied by Boehringer Mannheim GmbH, Mannheim, 
Germany. Plasma lipoproteins were isolated by density-gradient ultracentrifugation 
(Terpstra et al. 1981). The following fractions were obtained (density, d ;  g/ml): very-low- 
density lipoprotein (VLDL; d < 1.006), intermediate-density lipoprotein (IDL ; 1.006 < d 
< 1.019), low-density lipoprotein (LDL; 1.019 < d < 1.063), and high-density lipoprotein 
2 (HDL,; 1.063 < d < 1.125) and high-density lipoprotein 3 (HDL,; 1.125 < d < 1.210). 
Lipoprotein cholesterol was measured as plasma total cholesterol. 
Total faecal 3-cr bile acids were determined with the use of a test combination based on 
an enzymic, spectrofluorimetric method (Sterognost 3-or Flu; Nyegaard & Co, Oslo, 
Norway). 
Statistical analyses 
All statistical analyses were carried out with the SPSS/PC+ programme (SPSS Inc., 1986). 
The data were subjected to three-way ANOVA with type of N source (casein v. whey 
protein), form of N source (intact protein v. amino acid mixture), and amount of N source 
(150 v. 300 g protein or amino acid mixture/kg diet) as main effects. The probability of a 
type I error < 0.05 was taken as criterion of statistical significance. The main effects were 
also evaluated in selected, direct comparisons with the use of Student’s t test. When testing 
for effects of type, form and amount of N source in the diet, a P value of 0.017 was used 
to take into account the increased probability of a type I error because of multiple 
comparisons. 
Final body weights were similar between dietary groups (Table 4). Whey protein feeding 
slightly reduced food intake when compared with casein. Rats given amino acid mixtures 
RESULTS 
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Table 4. Growth performance and liver weight in the rats f e d  on the experimental diets f o r  
21 d? 
(Values are means with pooled standard errors for twelve rats per dietary group) 
Casein Whey-protein Statistical 
Protein or amino Casein Whey protein amino acids amino acids significance 
acid mixture Pooled (ANOVA)* of 
(g/kg feed ...) 150 300 150 300 150 300 150 300 SE effects of: 
Body wt (8) 
Day 0 93 93 94 94 93 95 95 95 2.6 
Day 21 176 187 174 174 165 181 173 170 5.0 T x A  
Feed intake 13.9 13.2 12.1 11.9 13.4 12.9 13.1 12.3 1.6 T 
(g/d, days 18-20) 
(g/kg body weight) 
Liver wt 52 55" 50 47t 48' 46' 52 47" 1 F , A , T x F ,  
T x A, A x  F 
T, type of N source (whey protein v. casein); A, amount of N source (150 v. 300 g protein or amino acid 
mixture/kg diet); F, form of N source (intact protein v. amino acid mixture); T x A. T x F, A x  F, T x A x F, 
interactions; t, a, f group comparisons for two groups with one dietary variable (P < 0,017): t, significant N type 
effect (intact whey protein v. casein or whey protein amino acids v. casein amino acids); a, significant N amount 
effect (150 v. 300 g protein or amino acid mixture/kg diet); f, significant N form effect (casein amino acids v. intact 
casein or whey protein amino acids v. intact whey protein). 
* P < 0.05. 
t For details of diets, see Tables 1-3. 
simulating either casein or whey protein consumed similar amounts of feed. Increasing N 
intake reduced feed intake irrespective of the nature of the N source. Feeding intact whey 
protein caused significantly lower liver weight than feeding casein. The amino acid mixture 
corresponding to casein produced lower liver weight than intact casein. Such an effect was 
not seen with whey protein amino acids. Apart from the groups given intact casein, 
increasing N intake lowered relative liver weight. 
At the low dietary protein level, plasma cholesterol concentrations were similar for rats 
given either intact whey protein or casein (Table 5). An increased intake of casein raised 
the group mean plasma cholesterol concentration, whereas an increased intake of whey 
protein had the opposite effect. Thus, an increment in protein intake resulted in a significant 
protein-type effect : whey protein v. casein significantly reduced plasma cholesterol 
concentration by about 35 YO. The plasma cholesterol lowering as induced by extra whey 
protein in the diet was most clearly reflected in the VLDL fraction (Table 6 ) .  The influence 
of the intact proteins on plasma free cholesterol mirrored that on plasma total cholesterol. 
At the high dietary N concentration the amino acid mixture simulating casein lowered 
plasma cholesterol concentrations when compared with intact protein (Table 5). The casein 
amino acids produced lower cholesterol concentrations in VLDL and IDL. Such an effect 
was not seen at the low dietary N concentration. The amino acid mixture simulating whey 
protein did not systematically influence plasma cholesterol concentration when compared 
with intact whey protein. The whey protein amino acids in the diet did not significantly alter 
plasma cholesterol concentrations when compared with casein amino acids. 
Dietary whey protein produced lower group mean plasma triacylglycerol concentrations 
than casein, but a corresponding N source effect was not found in rats fed on amino acid 
mixtures simulating either whey protein or casein (Table 5). The amino acid mixtures 
generally lowered triacylglycerols when compared with the intact proteins. Increasing 
intakes of intact proteins, but not of amino acid mixtures, reduced plasma triacylglycerols. 
Whey protein v. casein significantly reduced liver cholesterol concentrations, this effect 
being greater when dietary protein level was increased (Table 5). Such an effect of N source 
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Table 5. Plasma and liver chofesterof concentrations in rats fed on the experimental diets 
f o r  21 d? 
Casein Whey-protein Statistical 
Protein or amino Casein Whey protein amino acids amino acids significance 
acid mixture Pooled (ANOVA)* of 
(g/kg feed.. .) 150 300 150 300 150 300 150 300 SE effects of: 
Plasma cholesterol 
(mmol/l) 
Day 0 3.05 3.03 3.04 3.02 3.04 3.05 2.96 3.05 0.14 
Day 21 2.63 3.00 2-64 2.04".' 2.49 2.26' 207',' 2.35 0.14 T, F, T x A  X F  
T, F, T x F ,  
Plasma free 0.38 0.46 0.37 0,26a,t 033  0.34' 0.32 0.33' 0.02 T x A, T x F x A 
cholesterol 
(mmol/l) 
triacylgl ycerols 
(mmol/l) 
(mmol/g liver) 
acids &mol/d) 
Plasma 1.37 1.22 1.14 0.85 1.08 1.07 1.00 1.00 0.14 
Liver cholesterol 92.4 90.4 57.1' 38.6' 56.8' 43.2' 59.0 52.7 6.80 T, A, F, T x F 
Faecal 3-cr bile 49.2 50.7 53.7 41.9"' 43.9 41.1 39.2' 42.4 2.78 F, T x A x F  
T, type of N source (whey protein v .  casein); A, amount of N source (150 u. 300 g protein or amino acid 
mixture/kg diet); F, form of N source (intact protein v .  amino acid mixture); T x A, T x F, A x F, T x A x F, 
interactions; t, a, f group comparisons for two groups with one dietary variable (P < 0.017): t, significant N type 
effect (intact whey protein v .  casein or whey protein amino acids v .  casein amino acids); a, significant N amount 
effect (150 u. 300 g protein or amino acid mixture/kg diet); f, significant N form effect (casein amino acids v .  intact 
casein or whey protein amino acids u. intact whey protein). 
* P < 0.05. 
t For details of diets, see Tables 1-3. 
Table 6.  Distribution of cholesterol between plasma lipoproteins in rats fed the 
experimental diets for  21 dt  
Casein Whey-protein Statistical 
Protein or amino Casein Whey protein amino acids amino acids significance 
acid mixture Pooled (ANOVA)* of 
(g/kg feed). . . 150 300 150 300 150 300 150 300 SE effects of: 
Lipoprotein cholesterol 
(mmol/l whole plasma) 
VLDL cholesterol 098  0-94 066  0.46t 0.50' 0.39' 035' 0.37 0.08 T, F, T X  F 
IDL cholesterol 0.25 0.32 0.19 0.19 0.24 0.15 0.12t 0.18 0.04 T, F, T x A x F  
LDL cholesterol 0.22 0.40" 0.36 0.37 0.44' 0.43 0.38 0.43 0.05 F 
HDL, cholesterol 0.84 0.85 1.04 0.91 0.92 1.04 0.95 0.95 0.07 
HDL, cholesterol 010 014 0.10 0.11 0.10 0.10 010 0.11 0.02 
VLDL, very-low-density lipoprotein; IDL; intermediate-density lipoprotein. 
T, type of N source (whey protein v .  casein); A, amount of N source (150 v .  300 g protein or amino acid 
mixture/kg diet); F, form of N source (intact protein v .  amino acid mixture); T x A, T x F, A x F, T x A x F, 
interactions; t, a, f group comparisons for two groups with one dietary variable (P < 0,017): t, significant N type 
effect (intact whey protein v .  casein or whey protein amino acids v .  casein amino acids); a, significant N amount 
effect ( 1  50 v. 300 g protein or amino acid mixture/kg diet); f, significant N form effect (casein amino acids Y .  intact 
casein or whey protein amino acids v .  intact whey protein). 
* P < 0.05. 
t For details of diets, see Tables 1-3. 
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was not seen in rats fed on diets containing the amino acid mixtures. At the two dietary N 
concentrations the amino acid mixture simulating casein lowered liver cholesterol 
concentrations when compared with the intact protein. For whey protein at the high dietary 
N concentration there was an opposite tendency. 
At the high dietary protein level intact whey protein v. casein significantly reduced the 
faecal excretion of bile acids (Table 5). The two amino acid mixtures did not differently 
influence bile acid excretion. Apart from the diet containing the high concentration of 
whey-protein amino acids, the other diets with amino acids produced lower rates of bile 
acid excretion than the corresponding diets with intact proteins. 
DISCUSSION 
Conflicting results have been reported as to the effect of dietary whey protein v. casein on 
plasma and liver cholesterol concentrations in rats. Sautier et al. (1983), using non- 
balanced diets without added cholesterol, found that dietary whey protein produced lower 
plasma cholesterol concentrations than casein, while liver cholesterol concentration was 
not significantly reduced. Choi et al. (1989) did not show any effect of whey protein v. casein 
on plasma and liver cholesterol. In those two studies dietary protein concentration was 
about 200 g/kg feed. In the present study whey protein reduced liver cholesterol, but not 
plasma cholesterol, when given at  a dietary concentration of 150 g/kg feed. This 
corroborates the work of Lapre et al. (1989). However, 300 g whey protein/kg feed instead 
of an identical amount of casein markedly lowered both plasma and liver cholesterol levels. 
In rats fed on whey protein at the high level, cholesterol in VLDL was reduced. Since this 
lipoprotein fraction is a major carrier of plasma triacylglycerols, it is not surprising that 
group mean total triacylglycerol concentrations in plasma were decreased in rats given the 
high amount of whey protein. 
Thus, whey protein v. casein had cholesterol-lowering activity and, by definition, casein 
v. whey protein had cholesterol-elevating activity. To see whether the hypocholesterolaemic 
effect of whey protein can be explained by its amino acid composition, amino acid mixtures 
simulating either whey protein or casein were also fed. It is appreciated, however, that the 
effects of amino acid mixtures may not give information about the intact proteins. An 
intact protein cannot be simply replaced by an amino acid mixture resembling its 
composition because the order in which peptides or amino acids are released during 
digestion is characteristic for the intact protein. The differential effect of intact whey protein 
and casein on plasma and liver cholesterol levels was not seen with the amino acids 
simulating either whey protein or casein. The amino acid mixtures produced significantly 
different plasma cholesterol concentrations when compared with the intact corresponding 
proteins. The results could imply that the cholesterol-lowering activity of whey protein v. 
casein resides in different protein structure or non-protein components rather than in 
different amino acid composition per se. In contrast, the hypocholesterolaemic effect of 
dietary soya-bean protein v. casein in rats has been reproduced by feeding amino acid 
mixtures formulated to simulate these proteins (Yadav & Liener, 1977; Nagata et al. 1981). 
The hypocholesterolaemic effect of soya-bean protein v. casein may be explained by 
stimulation of faecal excretion of bile acids and neutral steroids (Beynen, 1990). In contrast, 
the mechanism underlying the hypocholesterolaemia produced by the feeding of whey 
protein instead of casein is not clear. In rabbits, whey protein v. casein slightly lowered 
plasma total cholesterol concentration, which was associated with increased rates of faecal 
excretion of neutral steroids and bile acids (Lovati et al. 1990). In rats, however, whey 
protein did not change the excretion of neutral steroids and bile acids in faeces (Sautier et 
al. 1983). In the present study whey protein at the high dietary N concentration significantly 
reduced the faecal excretion of bile acids. Thus, it is unlikely that in rats whey protein v. 
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casein inhibits re-absorption of bile acids as has been shown for soya-bean protein v. casein 
(Beynen, 1990). 
It is possible that, in rats fed on the high level of whey protein, cholesterol synthesis was 
inhibited when compared with their counterparts fed on casein. This is indicated by the 
observation that whey protein induced lower VLDL-cholesterol levels. The lower liver 
cholesterol concentrations in rats given whey protein could also point to a depressed de HOVO 
cholesterolgenesis, but the fact that cellular cholesterol usually acts as a feedback inhibitor 
of cholesterol synthesis speaks against this. Since cholesterol synthesized de novo in the liver 
is a major precursor of bile acids, the depressed excretion of bile acids in rats given whey 
protein instead of casein could indicate that whey protein inhibits cholesterol synthesis. 
Whether dietary whey protein v. casein indeed blocks hepatic cholesterol synthesis or, in 
other words, whether casein stimulates cholesterol synthesis compared with whey protein 
can only be proved by direct measurement of cholesterol synthesis. 
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